2011版《原发性骨质疏松症临床诊疗指南》解读

被引：43

作者：

徐苓

机构：

[1] 中国医学科学院北京协和医院妇产科

来源：

药品评价 | 2012年 / 9卷 / 07期

关键词：

骨质疏松; 危险因素; 风险评估; 诊断; 鉴别诊断; 指南;

D O I：

暂无

中图分类号：

R580 [];

学科分类号：

摘要：

<正>骨质疏松症(Osteoporosis,OP)是一种以骨量低下,骨微结构损坏,导致骨脆性增加,易发生骨折为特征的全身性骨病。这是一种骨骼的退化性疾病,伴随年龄增长,患病风险增加[1,2]。随着人类寿命延长和老龄化社会的到来,骨

引用

页码：9 / 13

页数：5

共 15 条

[1]

Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.[J].H A Bischoff-Ferrari;B Dawson-Hughes;H B Staehelin;J E Orav;A E Stuck;R Theiler;J B Wong;A Egli;D P Kiel;J Henschkowski.BMJ: British Medical Journal.2009, 7725

[2]

Long-term treatment of postmenopausal osteoporosis with strontium ranelate: Results at 8 years [J].

Reginster, J. Y. ;

Bruyere, O. ;

Sawicki, A. ;

Roces-Varela, A. ;

Fardellone, P. ;

Roberts, A. ;

Devogelaer, J. P. .

BONE, 2009, 45 (06) :1059-1064

[3]

European guidance for the diagnosis and management of osteoporosis in postmenopausal women [J].

Kanis, J. A. ;

Burlet, N. ;

Cooper, C. ;

Delmas, P. D. ;

Reginster, J. -Y. ;

Borgstrom, F. ;

Rizzoli, R. .

OSTEOPOROSIS INTERNATIONAL, 2008, 19 (04) :399-428

[4]

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].

Black, Dennis M. ;

Delmas, Pierre D. ;

Eastell, Richard ;

Reid, Ian R. ;

Boonen, Steven ;

Cauley, Jane A. ;

Cosman, Felicia ;

Lakatos, Peter ;

Leung, Ping Chung ;

Man, Zulema ;

Mautalen, Carlos ;

Mesenbrink, Peter ;

Hu, Huilin ;

Caminis, John ;

Tong, Karen ;

Rosario-Jansen, Theresa ;

Krasnow, Joel ;

Hue, Trisha F. ;

Sellmeyer, Deborah ;

Eriksen, Erik Fink ;

Cummings, Steven R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822

[5]

Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: Evidence from a comparative metaanalysis of randomized controlled trials [J].

Boonen, Steven ;

Lips, Paul ;

Bouillon, Roger ;

Bischoff-Ferrari, Heike A. ;

Vanderschueren, Dirk ;

Haentjens, Patrick .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04) :1415-1423

[6]

Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study [J].

Reginster, JY ;

Seeman, E ;

De Vernejoul, MC ;

Adami, S ;

Compston, J ;

Phenekos, C ;

Devogelaer, JP ;

Curiel, MD ;

Sawicki, A ;

Goemaere, S ;

Sorensen, OH ;

Felsenberg, D ;

Meunier, PJ .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (05) :2816-2822

[7]

Daily and intermittent oral ibandronate normalize bone turnover and provide significant reduction in vertebral fracture risk: results from the BONE study [J].

Delmas, PD ;

Recker, RR ;

Chesnut, CH ;

Skag, A ;

Stakkestad, JA ;

Emkey, R ;

Gilbride, J ;

Schimmer, RC ;

Christiansen, C .

OSTEOPOROSIS INTERNATIONAL, 2004, 15 (10) :792-798

[8]

Efficacy and safety of raloxifene 60 milligrams/day in postmenopausal Asian women [J].

Kung, AWC ;

Chao, HT ;

Huang, KE ;

Need, AG ;

Taechakraichana, N ;

Loh, FH ;

Gonzaga, F ;

Sriram, U ;

Ismail, NMN ;

Farooqi, A ;

Rachman, IA ;

Crans, GG ;

Wong, M ;

Thiebaud, D .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3130-3136

[9]

Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: Four-year results from a randomized clinical trial [J].

Delmas, PD ;

Ensrud, KE ;

Adachi, JD ;

Harper, KD ;

Sarkar, S ;

Gennari, C ;

Reginster, JY ;

Pols, HAP ;

Recker, RR ;

Harris, ST ;

Wu, WT ;

Genant, HK ;

Black, DM ;

Eastell, R .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (08) :3609-3617

[10]

A simple tool to identify Asian women at increased risk of osteoporosis [J].

Koh, LKH ;

Ben Sedrine, W ;

Torralba, TP ;

Kung, A ;

Fujiwara, S ;

Chan, SP ;

Huang, QR ;

Rajatanavin, R ;

Tsai, KS ;

Park, HM ;

Reginster, JY .

OSTEOPOROSIS INTERNATIONAL, 2001, 12 (08) :699-705

← 1 2 →